Product Description
Research combination containing CJC-1295 without DAC (Modified GRF) and Ipamorelin for investigating synergistic effects on growth hormone release pathways.
Specifications
Purity:99%+
Methodology:HPLC
Storage:2-8 C
Form:Lyophilized Powder
Features
- GHRH + GHS combo
- Synergistic research
Research Areas
GH Release PathwaysReceptor Synergy
